ISSN: 1948-5948
Journal of Microbial & Biochemical Technology
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

An Innovative Approach to Hospital Sanitization Using Probiotics: In Vitro and Field Trials

Vincenza La Fauci1*, Gaetano Bruno Costa1, Francesca Anastasi2, Alessio Facciolà2, Orazio Claudio Grillo1 and Raffaele Squeri1
1Department of Biomedical Sciences and Morphological and Functional Images, University of Messina, Messina, Italy
2Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Messina, Italy
Corresponding Author : Vincenza La Fauci
Department of Biomedical Sciences and Morphological and Functional Images
A.O.U. Policlinico “G. Martino”
Torre Biologica 1 Piano
Via Consolare Valeria,98125 MESSINA, Italy
Tel: +390902213620
Fax: +390902213351
E-mail: vlafauci@unime.it
Received April 14, 2015; Accepted May 20, 2015; Published May 30, 2015
Citation: La Fauci V, Costa GB, Anastasi F, Facciolà A, Grillo OC, et al. (2015) An Innovative Approach to Hospital Sanitization Using Probiotics: In Vitro and Field Trials. J Microb Biochem Technol 7:160-164.doi: 10.4172/1948-5948.1000198
Copyright: © 2015 La Fauci V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Journal of Microbial & Biochemical Technology

Abstract

Background: The nosocomial infections continue to be a problem, even in hospitals where meticulous sanitization procedures are in place. The most commonly used methods employ chemical disinfectants which carry some disadvantages.

Objective: To investigate the effectiveness of an innovative sanitization procedure using probiotic bacteria based on the principle of biological competition: Probiotic Cleaning Hygiene System (PCHS).

Methods: The study included survival tests and in vitro and field trials. The in vitro trials tested three surfaces (washbasin, floor and desk) in the absence of recontamination. Field trials were carried out in order to evaluate the efficacy of probiotics in the presence of contaminants and to study whether probiotics are able to contain pathogens over time. Samples were taken from the floor in a corridor and an inpatient room and the dispensary washbasin twice daily (pre-sanitization and post-sanitization).

Results: The in vitro tests on three surfaces, not subject to recontamination, resulted in an average reduction ranging from 92.2% to 99.9% after 24 h. From field trials it emerged that the bacterial count was totally eliminated for Enterococcus faecalis and Candida albicans and almost 100% elimination of Pseudomonas aeruginosa, Acinetobacter baumannii e Klebsiella pneumoniae on all three surfaces after only six hours even when recontaminated. However, less satisfactory results were attained for Staphylococcus aureus.

Conclusion: PCHS acts constantly and is durable over time due to the stabilization of a biofilm which is able to reduce and contain the proliferation of pathogenic microorganisms. Probiotics are therefore effective innovative products to sanitize the hospital environment.

Keywords
Hospital sanitization; Probiotics; Nosocomial infections
Introduction
Hospital infections continue to be a huge healthcare problem worldwide to which no facility, public or private, is immune. The importance of inanimate surfaces as sources of nosocomial pathogens has long been recognized/acknowledged [1-3]. Environmental sanitization is an essential and effective part of programs to prevent and control hospital infections [4]. Sanitization procedures in hospitals, combined with antibiotic prophylaxis for patients, are designed to reduce an d prevent the proliferation of microorganisms. Nevertheless, nosocomial infections continue to be a problem, even in hospitals where meticulous sanitization procedures are in place. The most common environmental sanitization methods involve the use of chemical disinfectants. However, these are not without disadvantages: 1) the limited effectiveness of biocides over time (normally 20-30 minutes after application, after which microorganisms multiply exponentially); 2) the ability of microorganisms to mutate thereby annihilating the biocidal effects; 3) increased pollution of the natural environment arising from the massive use of chemicals that may accumulate and persist over time. The seriousness of these problems prompted us to conduct trials using an innovative sanitization technique using probiotic bacteria adopting an approach based on the principle of biological competition in which the aim is no longer to destroy the microorganisms on surfaces, but to form a biofilm to counteract the proliferation of pathogens. Probiotic studies have attracted considerable interest in recent literature, particularly in view of increased bacterial resistance [3,5-7]. These products have long been used to reduce the occurrence and/or duration of diarrhoea attacks linked to antibiotics [8,9]; and in vitro trials are now underway to assess the possibility of using probiotics outside the human body on surfaces. Some studies have focused on the potential ability of a biofilm to inhibit bacterial growth on silicone materials used in the urogenital tract [10,11,13,15] oral cavity [12,14] and/or other matrices [10,16]. Recent trials have shown that probiotic bacteria may also be used to sanitize hospital environments in order to combat the increase in nosocomial pathogens [17,18]. Probiotic bacteria (Probiotics in progress/PIPs) are spores of Bacillus spp, and considered to be innocuous microorganisms as, unlike disinfectants, they do not act as biocides. They are able to colonize surfaces to which they are applied, thereby effectively counteracting the proliferation and survival of other types of bacteria, including germs, by means of “competitive exclusion”.
Materials and Methods
The aim of this study, carried out in the year 2013 at the University Hospital “G. Martino” in Messina (Italy), was to measure the reduction and elimination of pathogenic microorganisms using probiotics and thereby assess the effectiveness of this sanitization method. The Probiotic Cleaning Hygiene System (PCHS) was adopted for this study conducted in the UOC laboratories for Hospital Hygiene where both in vitro and field trials were conducted.
Sanitizing solution
The probiotic-based solution contained 1% of spores (30 × 106 CFU/ml) of Bacillus subtilis, Bacillus pumilus and Bacillus megaterium, in addition to ionic surfactants (0.6%), anionic surfactants (0.8%) and enzymes (amylases 0.02%) [18].
Microorganisms and growth media used
Strains of S. aureus, P. aeruginosa, K. pneumoniae, A. baumannii, E. faecalis and C. albicans, isolated from cases of nosocomial infections in hospitalized patients, were used for the in vitro trials. These strains were cultivated on the following respective media: Baird-Parker Agar, Cetrimide Agar, MacConkey Agar, Enterococcosel Agar and Sabouraud Dextrose Contact Agar.
Tryptic Soy Agar Contact (TSA) was used for the total microbial count (TMC) in field trials, in addition to the specific cultures for the same microorganisms tested in vitro. All bacterial strains were cultivated by incubation at 37ºC for 24-48 h.
Identification of microorganisms
Pathogenic strains were identified using API 20 NE for Pseudomonas spp, API 20 E for Enterobacteriaceae microorganisms including K. pneumoniae and A. baumannii, API Staph for S. aureus, and API AUX C for Candida spp.
Sanitization procedures
Sanitization was carried out using microfibre cloths, cleaned after each use following the manufacturer’s instructions. Dry surfaces were first dusted followed by wet cleaning using the probiotic liquid. The microfibre cloths were soaked in the solution and stored in clean containers until use. The sanitization steps were all carried out by the same trained staff member in order to minimize any variations in the procedure adopted. The solution used to treat surfaces was prepared in accordance with the manufacturer’s instructions for application of 1.5 × 106 spore/m2.
Survival tests
The above microbial strains were used in survival tests to contaminate the surfaces of a wash-basin, a floor and a desk in order to assess their survival in the external environment. For this purpose, we used solutions of the microbial strains with an initial count of about 1,5 × 103 CFU/m2. The bacterial count on contaminated surfaces was undertaken over an eight-day period.
In Vitro trials
In vitro trials were conducted over a two-week period in order to assess how effectively probiotics were able to compete against pathogenic bacteria from the hospital environment in the absence of external factors linked to recontamination. During these tests the three surfaces (washbasin, floor and desk) were first contaminated using sterile swabs soaked with the same solutions used for the survival tests and then sanitized using PIPs. Samples of each microorganism were taken three times daily: at 8:00 (pre-sanitization), 11:00 and 14:00 (post-sanitization).
Field trials
Field trials were carried out in the Thoracic and Vascular Surgical Ward over a three-month period (May-July 2013) in order to evaluate the efficacy of probiotics in the presence of a contamination related to the daily hospital activity of healthcare workers, inpatients and relatives and to study whether probiotics are able to contain pathogens over time. Samples were taken from the floor in a corridor and an inpatient room and the dispensary washbasin twice daily, at 8:00 (pre-sanitization) and 14:00 (post-sanitization). As control group, at the same time, we carried out a comparable microbiological monitoring in similar surfaces situated in the opposite part of the ward, subjected to the same type of recontamination and sanitized using normal chemical products.
Results
Survival tests
The tests conducted to assess the survival of the same strains used for in vitro trials, showed microorganisms were still alive after 24 or 48 h. E. faecalis and S. aureus were particularly robust, as they continued to survive in the external environment even after four and eight days respectively. Moreover, the latter showed a continuous and progressive growth until the day 4 after which it decreased to the level at zero time (Table 1).
In Vitro trials
The in vitro tests on three surfaces, not subject to recontamination, resulted in an average reduction ranging from 92.2% to 99.9% after 24 h (Table 2).
Analysis of the individual results for each contaminated surface and each pathogenic microorganism tested showed similar results for two of the materials (wooden desk and porcelain washbasin), since after three hours only P. aeruginosa survived on both surfaces while E. faecalis, survived only on the wooden desk. After six hours they disappeared from both the desk and washbasin. In contrast, all microorganisms were still alive after six hours on the linoleum floor. These differences arising from the different materials (wood, porcelain, and linoleum) were eradicated after 24/30 hours when all microorganisms were destroyed on all three surfaces. Comparison of the individual microorganisms demonstrated the following percentage reductions: S. aureus, 99.4% after 3 h, 99.5% after 6 h, 99.7% at 24 h and total destruction at 30 h; P. aeruginosa, 70.2% after 3 h, 90.0% after 6 h and 100.0% at 24 h; A. baumannii and K. pneumonia, 98.6% and 96.5% respectively after 3 h, 99.5% and 99.0% at 6h, and 99.9% and 99.5% at 24 h with total destruction after 27 h; E. faecalis 96.7% after 3 h and total destruction after 6 h; with similar results for C. albicans.
Field trials
Before the sanitation with PIPs, we evaluated the contamination rate of the ward by microbiological sampling using specific contact plates (not only floor, desk and washbasin but even beds, bedside tables and door handles). In these surfaces we found a contamination by S. aureus, E. faecalis, P. aeruginosa and C. albicans in the amount of 4 × 102 CFU/m2, 2,5 × 102 CFU/m2, 2 × 102 CFU/m2 and 0,5 × 102 CFU/m2 respectively. After that, destruction and/or reduction of each pathogenic microorganism was achieved by sanitization using the PCHS system over the trial period (from 6 May to 30 July). While in the survival test all microorganisms were still alive after 24 or 48 h, for E. faecalis and C. albicans the microbial count was totally eliminated (Figure 1-2). It also disappeared almost completely for P. aeruginosa on all three surfaces after only 6h, even when recontaminated (Figure 3). The probiotic system was equally as effective against A. baumannii and K. pneumoniae, for the first two months, while in the third month of trials six hours of contact were no longer enough to reduce bacterial count significantly, although growth continued to be contained particularly for the washbasin surface (Figure 4). The efficacy of PIPs was far less evident for S. aureus (Figure 5). Indeed, sanitization using PIP following recontamination was unable to act continuously to reduce bacterial growth even three months after treatment. This was most evident on ward floor surfaces. In the control group, we observed a constant and remarkable presence of S. aureus, P. aeruginosa and E. faecalis, in variable concentration, for all the period of the monitoring.
Discussion
Our study confirms that probiotics are able to reduce the growth of specific pathogenic microbial species namely: S. aureus, P. aeruginosa, K. pneumoniae, E. faecalis, A. baumannii and C. albicans. The in vitro tests allowed the reduction in microbial count of the pathogens to be verified under controlled conditions, thus verifying the efficacy of PIP to combat bacteria where there is no risk of recontamination. The field trials demonstrated that the bacterial count remained low over time following sanitization despite the surfaces treated being constantly exposed to the risk of recontamination by patients, healthcare workers and visitors. The results achieved improved as time progressed but this improvement was linked to the type of material treated. It was found that sanitization was was more effective on the porcelain washbasin than the linoleum flooring. This confirms that the continuous and constant action of the PCHS system over time is the result of the stabilization of the biofilm, which is able to reduce and contain the proliferation of microorganisms.
Both the in vitro and field trials demonstrated the efficacy of these products in containing the total microbial count; and this positive effect was found to persist throughout the trial albeit with some adverse variances for A. baumannii, K. pneumoniae and S. aureus. The results obtained for these pathogens differed from the others tested as the probiotic biofilm was unable to compete effectively for the entire duration of the trials undertaken. In the case of S. aureus this finding is probably linked to its greater resistance and vigour in the environment; as shown by the survival tests.
Probiotics are ecological, easy to use and biodegradable. They render the environment hygienically stable and are able to survive on and colonize non biological surfaces, combatting the proliferation of other bacteria. In this study they were also found to perform well on surfaces in the hospital environment that are subject to regular recontamination. Probiotics are therefore effective innovative products for sanitizing the hospital environment and constitute a valid “green” alternative to the chemical disinfectants used up to now. However, further trials are necessary to test the product on surfaces which expose hospitalized patients to the greatest risks of infection.
References


















Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc Advanced Bioprocess Products
Disc Advances in Bioprocess Technology
Disc Advances in Biotechniques
Disc Advances in Food Bioprocess Technology
Disc Affinity Purification
Disc Agricultural
Disc Agricultural biotechnology
Disc Anaerobic Biodegradation
Disc Analytical Chromatography
Disc Animal and Plant Nutrition
Disc Animal biotechnology
Disc Anthrax
Disc Anti-parasitic Agents
Disc Antibacterial Agents
Disc Antibodies
Disc Antifungal Agents
Disc Antimicrobial Chemotherapy
Disc Antimicrobial Drugs
Disc Antimicrobial Peptide
Disc Antimicrobial Research
Disc Antimicrobial Resistance
Disc Antiprotozoals
Disc Antiseptics
Disc Antiviral Agents
Disc Applied Biotechnology
Disc Aseptic processing
Disc Bacteraemia
Disc Bacterial Ecology
Disc Bacterial Genomics
Disc Bacterial Infections
Disc Bacterial Toxin
Disc Bactericidal Drugs
Disc Bacteriology
Disc Bacteriostatic Drugs
Disc Beneficial Microorganisms in Food
Disc Beverage Industry
Disc Biocatalysis
Disc Biochemical Methods
Disc Biochemical Process
Disc Biochemistry
Disc Biodegradable Balloons
Disc Biodegradable Confetti
Disc Biodegradable Diapers
Disc Biodegradable Plastics
Disc Biodegradable Sunscreen
Disc Biodegradation
Disc Biofertilizers Technology
Disc Biological Activity
Disc Biomaterial implants
Disc Biomedical Chromatography
Disc Biomolecules
Disc Bioprocess Engineering
Disc Bioprocess Industry and Market Analysis
Disc Bioprocess Manufacturing
Disc Bioprocess Modelling
Disc Bioprocess and Systems Engineering
Disc Bioprocessing and Biopharma Manufacturing
Disc Bioremediation Bacteria
Disc Bioremediation Oil Spills
Disc Bioremediation Plants
Disc Bioremediation Products
Disc Biotechnology applications
Disc Blood Biochemistry
Disc Cancer Progression and Diagnostics
Disc Capillary Electrochromatography
Disc Carbohydrate Metabolism
Disc Carbohydrates Biochemistry
Disc Cardiac Markers
Disc Cardiovascular biomaterials
Disc Cellular and molecular Biochemistry
Disc Chromatography
Disc Clinical Biochemistry
Disc Clinical Chemistry
Disc Clinical Microbiology
Disc Coagulase Test
Disc Contamination
Disc Decomposers
Disc Deuterium Exchange Mass Spectrometry
Disc Diagnosis
Disc Diagnosis and treatment of Infectious Disease
Disc Diagnostics
Disc Electrolytes
Disc Electron Capture Dissociation Mass Spectroscopy
Disc Electrophoresis
Disc Electrospray Tandem Mass Spectrometry Newborn Screening
Disc Enzyme Technology
Disc Escherichia coli
Disc Ex Situ Bioremediation
Disc Experimental Food Microbiology
Disc Extraction Chromatography
Disc Fermentation
Disc Fermentation Industrial Microbiology
Disc Filtration
Disc Fishery biochemistry
Disc Food Additives
Disc Food Adulteration
Disc Food Allergens
Disc Food Biochemistry
Disc Food Borne Diseases
Disc Food Contamination
Disc Food Hazards
Disc Food Hygiene
Disc Food Hygiene Regulations
Disc Food Intoxication
Disc Food Labeling
Disc Food Microbes
Disc Food Microbiology
Disc Food Poisoning
Disc Food Quality Assurance
Disc Food Regulations
Disc Food Research International Standards (Food Research Europe, Food Research USA)
Disc Food Safety
Disc Food Safety and Quality
Disc Food Spoilage
Disc Food allergies
Disc Food and Beverage Technology
Disc Food and Feed Chemistry
Disc Food industry
Disc Food poison
Disc Food preservation
Disc Food science technology
Disc Fourier Transform Mass Spectrometry
Disc GC-MS
Disc Gas Chromatography
Disc Gas Chromatography Mass Spectrometry
Disc Genetic Diagnostics
Disc Genetic Testing
Disc Genomics in Infectious Diseases
Disc Good nutrition
Disc HPLC
Disc HPTLC
Disc Heavy Metal Bioremediation
Disc Host-Pathogen Interactions
Disc Imaging Mass Spectrometry
Disc Immuno Affinity Chromatography
Disc In Situ Bioremediation
Disc Industrial Bioprocessing
Disc Industrial Food Microbiology
Disc Industrial Microbiology
Disc Infection Control
Disc Inorganic Chemistry
Disc Inorganic biochemistry
Disc Intestinal Parasites
Disc Ion-exchange chromatography
Disc LC-MS
Disc Leprosy
Disc Liquid Chromatography
Disc Liquid Chromatography Mass Spectrometry
Disc Liquid Liquid Extraction
Disc Listeriosis
Disc Liver Diseases
Disc Liver Function Tests
Disc Lyme Disease
Disc MALDI
Disc Market Analysis of Food Testing
Disc Mass Spectrometry
Disc Mass Spectrometry Based Quantitative Metabolomics
Disc Mass Spectrometry in Medicine
Disc Mass Spectroscopy in Forensic Studies
Disc Medical Biochemistry
Disc Membrane Biochemistry
Disc Metabolites
Disc Method Validation
Disc Microbial Assay
Disc Microbial Assay of Antibiotic
Disc Microbial Biofuels
Disc Microbial Biosensor
Disc Microbial Fermentation
Disc Microbial Nutrition
Disc Microbiology
Disc Microbiology and Immunology
Disc Microbiology and Immunology Research
Disc Microbiology and Pathology
Disc Microorganism
Disc Minimum Inhibitory Concentration
Disc Molecular Diagnostics
Disc Molecular Forensics
Disc Morphology
Disc Multi Parametric Molecular Diagnostics
Disc Mycobacterium
Disc Mycology
Disc Mycoremediation
Disc Nano Chemistry
Disc Nano biotechnology
Disc Non Biodegradable
Disc Parasitic Infection
Disc Parasitic Worms
Disc Parasitology
Disc Pasteurisation
Disc Pathogen
Disc Pesticides
Disc Pesticides Biochemistry
Disc Petrochemistry
Disc Pharmaceutical Bioprocessing
Disc Phytoremediation
Disc Pigments
Disc Preparative Biochemistry
Disc Prevention of Contamination
Disc Principles of Diagnosis
Disc Protein Biochemistry
Disc Protein Folding by Mass Spectrometry
Disc Protein Mass Spectrometry
Disc Protein Purification
Disc Renal Function Test
Disc Rickettsioses
Disc Safe Food Handling Practices
Disc Salmonella
Disc Salmonellosis
Disc Selective Pressure
Disc Selective Toxicity
Disc Separation Techniques
Disc Sewage Water Treatment
Disc Soil Biochemistry
Disc Soil Bioremediation
Disc Soil organism
Disc Stem Cell Bioprocessing
Disc Sterilization
Disc Streptococcus
Disc Super Critical Fluid Chromatography
Disc Synthetic High Polymers
Disc Tandem Mass Spectrometry
Disc Transformation
Disc Types of Upwelling
Disc Ultrasound Technologies in Food Industry
Disc Virology
Disc Waste Degredation
Disc White/industrial biotechnology
Disc Xenobiotics
Disc Zoonotic Bacterial Diseases
Disc clinical Microbial Pathology
 
Recommended Journals
Disc Antimicrobial Agents Journal
Disc Molecular Diagnostics Journal
Disc Medical Biochemistry Journal
Disc Industrial Chemistry Journal
Disc Mass Spectrometry Journal
Disc Chromatography Journal
Disc Molecular Biology Journal
Disc Bioprocessing Journal
Disc Analytical Biochemistry Journal
Disc Food Microbiology Journal
Disc Industrial Microbiology Journal
Disc Biotechnology Journal
Disc Bioremediation Journal
Disc Bacteriology Journal
Disc Medical Microbiology Journal
  View More»
 
Recommended Conferences
Disc Water Microbiology Congress
July 18-20, 2016, Chicago, USA
Disc Veterinary Microbiology Summit
July 18-20, 2016, Chicago, USA
Disc Industrial Microbiology Conference
Aug 1-3, 2016, Frankfurt, Germany
Disc 6th Clinical Microbiology and Microbial Genomics Congress
Oct 24-26, 2016, Rome, Italy
Disc  7th World Congress and Expo onApplied Microbiology
Nov 10-12, 2016, Istanbul, Turkey
View More»
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11203
  [From(publication date):
June-2015 - May 25, 2016]
  Breakdown by view type
  HTML page views : 7477
  PDF downloads :3726
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version